2 unknown, 1 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow gp96: new trials by email Literature Review of gp96 trials Research Report on gp96
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer gp96 - Liver Cancer | Phase 2 / Phase 3 | Unknown | Cure&Sure Biotech Co., LTD | 80 | 2019-12-19 | 2019-12-20 |
| A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 gp96, Temozolomide, radiotherapy - Glioma of Brain | Phase 2 | Unknown | Cure&Sure Biotech Co., LTD | 150 | 2019-08-21 | 2020-03-12 |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma HSPPC-96, Standard Surgical Resection - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 96 | 2005-11-18 | 2021-05-13 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Liver Neoplasms (1)
Cure&Sure Biotech Co., LTD (2) · University of California, San Francisco (1)
China (1) · United States (1)
P50CA097257 (1), R01CA164714 (1)